Cable Hill Partners, LLC Ionis Pharmaceuticals Inc Transaction History

Cable Hill Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 06, 2019	SELL	$62.09 - $86.14 $14,901 - $20,673	-240 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$42.88 - $53.7 $24,613 - $30,823	-574 Reduced 70.52%	240 $11,000
Q4 2017 Feb 22, 2018	SELL	$50.3 - $64.39 $8,752 - $11,203	-174 Reduced 17.61%	814 $40,000
Q3 2017 Oct 27, 2017	BUY	$45.56 - $59.57 $43,646 - $57,068	958 Added 3193.33%	988 $50,000
Q2 2017 Aug 14, 2017	BUY	N/A	30	30 $2,000

402

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $4.83B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Cable Hill Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Cable Hill Partners, LLC with notifications on news.